CUV 0.71% $14.09 clinuvel pharmaceuticals limited

Ann: CLINUVEL Newsletter II - March 2024, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 845 Posts.
    lightbulb Created with Sketch. 1158
    I have never heard such an amazing and bullish statement from a company intent on restoring market valuation. This was in reference to a FIRST share buyback.

    "We have chosen the moment of a repurchase as first clinical results for 2024 are published, and we will
    keep at it until those who gamble against the Company have understood the message. Given the
    expected future cash flows, we are in the position to prolong the program when required"


    That is really great, as I mentioned the buyback is only using a tiny percentage of cash reserves and when it's completed they will have banked another $30+ Million in cash and can easily go again. Sounds like they have had enough of the manipulation too and are intent on changing the narrative.

    All IMO DYOR



 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.